Australia - Lipid Modifying Medicine Use
Since 2014, Australia Lipid Modifying Medicine Use rose 1.4% year on year. At 141.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 7 comparing other countries in Lipid Modifying Medicine Use. Australia is overtaken by Canada, which was number 6 at 141.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Czech Republic at 140.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark topped the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 3.5% compared to 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +18.8% per year, while Slovakia recorded the worst performance at -8.7% per year.
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 141.20 |
| 2018 | 138.80 |
| 2017 | 134.10 |
| 2016 | 133.50 |
| 2015 | 134.00 |
How does Australia rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
| 6 |
#6
Canada
|
142 | 2019 | +8.8 % | +7.1 % | View data | |
| 7 |
#7
Australia
|
141 | 2019 | +1.7 % | +1.4 % | View data | |
| 8 |
#8
Czech Republic
|
140 | 2019 | +3.6 % | +4.5 % | View data | |